Anemia, Refractory, with Excess of Blasts
"Anemia, Refractory, with Excess of Blasts" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells.
| Descriptor ID |
D000754
|
| MeSH Number(s) |
C15.378.071.400.080 C15.378.190.625.062.080
|
| Concept/Terms |
Anemia, Refractory, with Excess of Blasts- Anemia, Refractory, with Excess of Blasts
- Leukemia, Smouldering
- Smouldering Leukemia
- RAEM
- Refractory Anemia with Excess of Blasts
- Leukemia, Smoldering
- Leukemias, Smoldering
- Smoldering Leukemia
- Smoldering Leukemias
- RAEB
|
Below are MeSH descriptors whose meaning is more general than "Anemia, Refractory, with Excess of Blasts".
Below are MeSH descriptors whose meaning is more specific than "Anemia, Refractory, with Excess of Blasts".
This graph shows the total number of publications written about "Anemia, Refractory, with Excess of Blasts" by people in this website by year, and whether "Anemia, Refractory, with Excess of Blasts" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 1 | 0 | 1 |
| 1996 | 0 | 3 | 3 |
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 2 | 2 | 4 |
| 2000 | 2 | 0 | 2 |
| 2001 | 2 | 3 | 5 |
| 2002 | 2 | 2 | 4 |
| 2003 | 2 | 3 | 5 |
| 2004 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2010 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anemia, Refractory, with Excess of Blasts" by people in Profiles.
-
Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning. Cancer. 2017 Jul 15; 123(14):2661-2670.
-
De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with =30% blasts in older adults: a Bone Marrow Pathology Group study. Am J Hematol. 2014 Nov; 89(11):E193-9.
-
Age-related changes of healthy bone marrow cell signaling in response to growth factors provide insight into low risk MDS. Cytometry B Clin Cytom. 2014 Nov; 86(6):383-96.
-
Recent advances in the diagnosis and classification of myeloid neoplasms--comments on the 2008 WHO classification. Int J Lab Hematol. 2010 Oct; 32(5):461-76.
-
Primary myelodysplastic syndrome in Jordan: a single-centre experience. Med Princ Pract. 2009; 18(5):351-5.
-
Myeloblast phenotypic changes in myelodysplasia. CD34 and CD117 expression abnormalities are common. Am J Clin Pathol. 2006 Jun; 125(6):884-94.
-
Phase II study of low-dose topotecan in myelodysplastic syndromes: a Hoosier Oncology Group (HOG) study. Leuk Res. 2004 Jan; 28(1):49-52.
-
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia. Blood. 2004 Apr 01; 103(7):2799-801.
-
Effect of circulating blasts at time of complete remission on subsequent relapse-free survival time in newly diagnosed AML. Blood. 2003 Nov 01; 102(9):3097-9.
-
Empirical examination of the neutrophil criterion (>1500 microl(-1)) currently needed to declare CR in AML. Leuk Res. 2003 Jun; 27(6):475-9.